Evidenzbasierte und interdisziplinär konsentierte versorgungspfade für patientinnen und patienten mit morbus Crohn oder colitis ulcerosa

Translated title of the contribution: Evidence-based and consented pathways for patients with inflammatory bowel diseases (IBD)

Helner Raspe*, S. Conrad, C. Muche-Borowski

*Corresponding author for this work
21 Citations (Scopus)

Abstract

Crohn's disease and ulcerative colitis are diseases characterized by remission and relapse, an early age of onset and restrictions on activities and participation. IBD patients need a comprehensive, easily accessible and problem-oriented health care. This requires the integration and coordination of different health care sectors, medical and non-medical professionals, social and health care facilities and funding agencies. The pathways to guide patients through integrated health care were based on clinical considerations, interviews with patients and specialists, systematically searched evidence and results of a questionnaire survey. Within a systematic assessment-assignment approach relevant problems were identified and subsequently related to different medical and non-medical professionals, health care services and medical sectors. The pathways further imply (1) medical care according to evidence-based guideline recommendations, (2) patient education programs to foster shared decision making and self-management and (3) suggestions for further research. The pathways were consented in a consensus conference using nominal group process methods. Their feasibility and effect will be evaluated within a regional implementation project.

Translated title of the contributionEvidence-based and consented pathways for patients with inflammatory bowel diseases (IBD)
Original languageGerman
JournalZeitschrift fur Gastroenterologie
Volume47
Issue number6
Pages (from-to)541-562
Number of pages22
ISSN0044-2771
DOIs
Publication statusPublished - 06.2009

Fingerprint

Dive into the research topics of 'Evidence-based and consented pathways for patients with inflammatory bowel diseases (IBD)'. Together they form a unique fingerprint.

Cite this